224 related articles for article (PubMed ID: 34728268)
1. Complications of lipodystrophy syndromes.
Akinci G; Celik M; Akinci B
Presse Med; 2021 Nov; 50(3):104085. PubMed ID: 34728268
[TBL] [Abstract][Full Text] [Related]
2. A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalities.
Ozgen Saydam B; Sonmez M; Simsir IY; Erturk MS; Kulaksizoglu M; Arkan T; Hekimsoy Z; Cavdar U; Akinci G; Demir T; Altay CT; Mihci E; Secil M; Akinci B
Endocr Res; 2019; 44(1-2):46-54. PubMed ID: 30182761
[TBL] [Abstract][Full Text] [Related]
3. Lipodystrophies-Disorders of the Fatty Tissue.
Knebel B; Müller-Wieland D; Kotzka J
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233602
[TBL] [Abstract][Full Text] [Related]
4. [Therapy resistant diabetes mellitus and lipodystrophy: leptin therapy leads to improvement].
Jazet IM; Jonker JT; Wijngaarden MA; Lamb H; Smelt AH
Ned Tijdschr Geneeskd; 2013; 157(4):A5482. PubMed ID: 23343738
[TBL] [Abstract][Full Text] [Related]
5. Lipodystrophy as a target to delay premature aging.
Costa DG; Ferreira-Marques M; Cavadas C
Trends Endocrinol Metab; 2024 Feb; 35(2):97-106. PubMed ID: 37968143
[TBL] [Abstract][Full Text] [Related]
6. Genetics of Lipodystrophy.
Lightbourne M; Brown RJ
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):539-554. PubMed ID: 28476236
[TBL] [Abstract][Full Text] [Related]
7. Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.
Vatier C; Vantyghem MC; Storey C; Jéru I; Christin-Maitre S; Fève B; Lascols O; Beltrand J; Carel JC; Vigouroux C; Bismuth E
Curr Med Res Opin; 2019 Mar; 35(3):543-552. PubMed ID: 30296183
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Cellular Bases of Lipodystrophy Syndromes.
Zammouri J; Vatier C; Capel E; Auclair M; Storey-London C; Bismuth E; Mosbah H; Donadille B; Janmaat S; Fève B; Jéru I; Vigouroux C
Front Endocrinol (Lausanne); 2021; 12():803189. PubMed ID: 35046902
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.
Akinci B; Meral R; Oral EA
Curr Diab Rep; 2018 Nov; 18(12):143. PubMed ID: 30406415
[TBL] [Abstract][Full Text] [Related]
10. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
[TBL] [Abstract][Full Text] [Related]
11. Leptin replacement therapy in the management of lipodystrophy syndromes.
Vigouroux C; Mosbah H; Vatier C
Ann Endocrinol (Paris); 2024 Jun; 85(3):201-204. PubMed ID: 38871500
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function.
Bruder-Nascimento T; Kress TC; Belin de Chantemele EJ
F1000Res; 2019; 8():. PubMed ID: 31656583
[TBL] [Abstract][Full Text] [Related]
13. Approach to the Patient With Lipodystrophy.
Fourman LT; Grinspoon SK
J Clin Endocrinol Metab; 2022 May; 107(6):1714-1726. PubMed ID: 35137140
[TBL] [Abstract][Full Text] [Related]
14. How to diagnose a lipodystrophy syndrome.
Vantyghem MC; Balavoine AS; Douillard C; Defrance F; Dieudonne L; Mouton F; Lemaire C; Bertrand-Escouflaire N; Bourdelle-Hego MF; Devemy F; Evrard A; Gheerbrand D; Girardot C; Gumuche S; Hober C; Topolinski H; Lamblin B; Mycinski B; Ryndak A; Karrouz W; Duvivier E; Merlen E; Cortet C; Weill J; Lacroix D; Wémeau JL
Ann Endocrinol (Paris); 2012 Jun; 73(3):170-89. PubMed ID: 22748602
[TBL] [Abstract][Full Text] [Related]
15. Metreleptin treatment of non-HIV lipodystrophy syndromes.
Chevalier B; Lemaitre M; Leguier L; Mapihan KL; Douillard C; Jannin A; Espiard S; Vantyghem MC
Presse Med; 2021 Nov; 50(3):104070. PubMed ID: 34571177
[TBL] [Abstract][Full Text] [Related]
16. Leptin-replacement therapy for lipodystrophy.
Oral EA; Simha V; Ruiz E; Andewelt A; Premkumar A; Snell P; Wagner AJ; DePaoli AM; Reitman ML; Taylor SI; Gorden P; Garg A
N Engl J Med; 2002 Feb; 346(8):570-8. PubMed ID: 11856796
[TBL] [Abstract][Full Text] [Related]
17. [Recognize rare diseases by the adipose tissue : Lipodystrophy-actually simple but nevertheless often overlooked].
Wabitsch M; V Schnurbein J
Internist (Berl); 2020 Oct; 61(10):1063-1075. PubMed ID: 32930809
[TBL] [Abstract][Full Text] [Related]
18. Partial lipodystrophy: Clinical presentation and treatment.
Mosbah H; Vatier C; Vigouroux C
Ann Endocrinol (Paris); 2024 Jun; 85(3):197-200. PubMed ID: 38871513
[TBL] [Abstract][Full Text] [Related]
19. The liver diseases of lipodystrophy: the long-term effect of leptin treatment.
Safar Zadeh E; Lungu AO; Cochran EK; Brown RJ; Ghany MG; Heller T; Kleiner DE; Gorden P
J Hepatol; 2013 Jul; 59(1):131-7. PubMed ID: 23439261
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities and Survival in Patients With Lipodystrophy: An International Chart Review Study.
Akinci B; Oral EA; Neidert A; Rus D; Cheng WY; Thompson-Leduc P; Cheung HC; Bradt P; Foss de Freitas MC; Montenegro RM; Fernandes VO; Cochran E; Brown RJ
J Clin Endocrinol Metab; 2019 Nov; 104(11):5120-5135. PubMed ID: 31314093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
